Cadence Design Systems, Inc. (CDNS)

FY2025 revenue grew approximately 15% to $4.7B, outpacing most enterprise software peers and matching Synopsys's growth rate. The growth is broad-based across digital, custom IC, and IP segments. Importantly, this growth is high-quality — predominantly recurring with 90%+ retention rates — not one-time license spikes.

Cadence and Synopsys collectively control 60-65% of the EDA market, with Cadence holding roughly 30%. The company has been gaining share in verification and IP blocks, critical areas as chip complexity increases. Smaller competitors like Siemens EDA struggle to invest at the same R&D intensity. The duopoly is strengthening, not weakening.

EDA tools are mission-critical for chip designers — the cost of Cadence licenses is trivial relative to the $500M+ cost of a chip tape-out at advanced nodes. This creates extreme pricing inelasticity. Annual contract escalators of 5-8% are accepted without pushback because the alternative is catastrophic design delays.

Cadence.AI integrating machine learning into design flows is genuinely accelerating customer productivity and deepening lock-in. The acquisition of OpenEye Scientific for molecular simulation extends the company into computational biology. Palladium Z3 emulation platform and Verisium AI-driven verification are category-leading products.

Switching EDA tools mid-project is essentially impossible — it would require re-verifying billions of transistors and retraining entire engineering teams. Design flows are deeply customized around Cadence toolchains, with scripts, libraries, and methodologies built up over years. No rational chip company would undertake this risk.

Cadence benefits from an ecosystem network effect: foundries (TSMC, Samsung, Intel) certify their process design kits (PDKs) for Cadence tools, and IP vendors optimize their blocks for Cadence flows. The more designers use Cadence, the more the ecosystem builds around it, making it harder for alternatives to gain traction.

Cadence holds thousands of patents covering algorithms fundamental to chip design — timing analysis, place-and-route optimization, signal integrity simulation. These patents represent decades of accumulated R&D investment (~$1.5B annually). Export controls on advanced EDA tools to China also create a geopolitical moat dimension.

EDA is a pure software business with minimal capex requirements. Cadence generates 30%+ free cash flow margins with the bulk of costs in R&D personnel. The capital-light model enables robust buybacks and strategic acquisitions without stressing the balance sheet. Operating leverage is significant as revenue scales.

FY2026 EPS estimates have been revised upward 10-12% over the past year as AI-driven EDA demand exceeds expectations. The revision trend is strongly positive and broad-based across sell-side coverage. The only caution is that estimates now embed 15%+ growth for multiple years, creating a high bar.

Cadence is firmly in the 'AI picks and shovels' narrative — every AI chip requires EDA tools, making Cadence an indirect beneficiary of the entire AI hardware buildout. This narrative is durable and factually grounded. The China export control angle adds geopolitical complexity but hasn't materially impacted revenue to date.

CEO Anirudh Devgan has executed flawlessly since taking the helm, accelerating growth while expanding margins. R&D allocation is strategically sound — investing in AI-enhanced tools and adjacent markets (computational biology, system analysis) without diluting the core EDA franchise. The OpenEye and BETA CAE acquisitions expand TAM thoughtfully.